rs4143999

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000554976.5(TDP1):​n.-759G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.154 in 157,512 control chromosomes in the GnomAD database, including 2,761 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.16 ( 2709 hom., cov: 33)
Exomes 𝑓: 0.11 ( 52 hom. )

Consequence

TDP1
ENST00000554976.5 non_coding_transcript_exon

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.934

Publications

10 publications found
Variant links:
Genes affected
TDP1 (HGNC:18884): (tyrosyl-DNA phosphodiesterase 1) The protein encoded by this gene is involved in repairing stalled topoisomerase I-DNA complexes by catalyzing the hydrolysis of the phosphodiester bond between the tyrosine residue of topoisomerase I and the 3-prime phosphate of DNA. This protein may also remove glycolate from single-stranded DNA containing 3-prime phosphoglycolate, suggesting a role in repair of free-radical mediated DNA double-strand breaks. This gene is a member of the phospholipase D family and contains two PLD phosphodiesterase domains. Mutations in this gene are associated with the disease spinocerebellar ataxia with axonal neuropathy (SCAN1). [provided by RefSeq, Aug 2016]
TDP1 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Orphanet
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AR Classification: NO_KNOWN Submitted by: King Faisal Specialist Hospital and Research Center

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000554976.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.299 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000554976.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TDP1
ENST00000554976.5
TSL:2
n.-759G>A
non_coding_transcript_exon
Exon 1 of 18ENSP00000452042.1G3V4W8
TDP1
ENST00000554976.5
TSL:2
n.-759G>A
5_prime_UTR
Exon 1 of 18ENSP00000452042.1G3V4W8

Frequencies

GnomAD3 genomes
AF:
0.155
AC:
23619
AN:
152092
Hom.:
2700
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.304
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.212
Gnomad ASJ
AF:
0.0706
Gnomad EAS
AF:
0.201
Gnomad SAS
AF:
0.218
Gnomad FIN
AF:
0.0759
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.0637
Gnomad OTH
AF:
0.135
GnomAD4 exome
AF:
0.109
AC:
577
AN:
5302
Hom.:
52
Cov.:
0
AF XY:
0.118
AC XY:
356
AN XY:
3026
show subpopulations
African (AFR)
AF:
0.161
AC:
10
AN:
62
American (AMR)
AF:
0.230
AC:
40
AN:
174
Ashkenazi Jewish (ASJ)
AF:
0.100
AC:
6
AN:
60
East Asian (EAS)
AF:
0.173
AC:
9
AN:
52
South Asian (SAS)
AF:
0.201
AC:
271
AN:
1348
European-Finnish (FIN)
AF:
0.0747
AC:
13
AN:
174
Middle Eastern (MID)
AF:
0.0500
AC:
1
AN:
20
European-Non Finnish (NFE)
AF:
0.0639
AC:
201
AN:
3146
Other (OTH)
AF:
0.0977
AC:
26
AN:
266
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
25
50
75
100
125
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.156
AC:
23680
AN:
152210
Hom.:
2709
Cov.:
33
AF XY:
0.160
AC XY:
11910
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.304
AC:
12604
AN:
41516
American (AMR)
AF:
0.213
AC:
3259
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0706
AC:
245
AN:
3470
East Asian (EAS)
AF:
0.201
AC:
1043
AN:
5182
South Asian (SAS)
AF:
0.218
AC:
1050
AN:
4820
European-Finnish (FIN)
AF:
0.0759
AC:
805
AN:
10606
Middle Eastern (MID)
AF:
0.0850
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
0.0637
AC:
4333
AN:
68006
Other (OTH)
AF:
0.138
AC:
291
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
948
1896
2845
3793
4741
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
248
496
744
992
1240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.102
Hom.:
1816
Bravo
AF:
0.172
Asia WGS
AF:
0.231
AC:
802
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
7.1
DANN
Benign
0.88
PhyloP100
-0.93
PromoterAI
-0.018
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4143999;
hg19: chr14-90421493;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.